These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31480)

  • 21. 5-Piperazinylalkyl-2(3H)-oxazolones with neuroleptic activity.
    Cascio G; Manghisi E; Fregnan G
    J Med Chem; 1989 Oct; 32(10):2241-7. PubMed ID: 2571727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic receptors: stereoselectivity for neuroleptic enantiomers.
    Seeman P; Westman K; Protiva M; Jílek J; Jain PC; Saxena AK; Anand N; Humber L; Philipp A
    Eur J Pharmacol; 1979 Jun; 56(3):247-51. PubMed ID: 38971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotropic agents: synthesis and antipsychotic activity of substituted beta-carbolines.
    Abou-Gharbia M; Patel UR; Moyer JA; Muth EA
    J Med Chem; 1987 Jun; 30(6):1100-5. PubMed ID: 2884314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic 4-aryltetrahydropyrrolo[3,4-b]indoles.
    Welch WM; Harbert CA; Weissman A
    J Med Chem; 1980 Jun; 23(6):704-7. PubMed ID: 6104734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
    Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
    Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents.
    Yevich JP; New JS; Smith DW; Lobeck WG; Catt JD; Minielli JL; Eison MS; Taylor DP; Riblet LA; Temple DL
    J Med Chem; 1986 Mar; 29(3):359-69. PubMed ID: 2869146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
    Sato M; Arimoto M; Ueno K; Kojima H; Yamasaki T; Sakurai T; Kasahara A
    J Med Chem; 1978 Nov; 21(11):1116-20. PubMed ID: 31476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 10-(Alkylamino)-4H-thieno[3,4-b][1,5]benzodiazepines. A novel class of potential neuroleptic agents.
    Press JB; Hofmann CM; Eudy NH; Fanshawe WJ; Day IP; Greenblatt EN; Safir SR
    J Med Chem; 1979 Jun; 22(6):725-31. PubMed ID: 37338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is dopamine antagonism a requisite of neuroleptic activity?
    Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental evaluation of the possible neuroleptic activity of clomipramine.
    Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1978; 22(3):263-9. PubMed ID: 31334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.
    Arnt J; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Eur J Pharmacol; 1982 Dec; 86(2):185-98. PubMed ID: 6130958
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.
    Cohen SL; Knight M; Tamminga CA; Chase TN
    Eur J Pharmacol; 1982 Sep; 83(3-4):213-22. PubMed ID: 6129145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL; Tabak J; Ohashi T; Goldstein M
    Psychopharmacol Commun; 1975; 1(5):501-10. PubMed ID: 7003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug.
    Uchida S; Honda F; Otsuka M; Satoh Y; Mori J; Ono T; Hitomi M
    Arzneimittelforschung; 1979; 29(10):1588-94. PubMed ID: 42413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of some 2-amino-4-aryl-3H-1,5-benzodiazepine analogues of clozapine.
    Ellefson CR; Woo CM; Miller A; Kehr JR
    J Med Chem; 1978 Sep; 21(9):952-7. PubMed ID: 31487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.
    Agai-Csongor E; Nógrádi K; Galambos J; Vágó I; Bielik A; Magdó I; Ignácz-Szendrei G; Keseru GM; Greiner I; Laszlovszky I; Schmidt E; Kiss B; Sághy K; Laszy J; Gyertyán I; Zájer-Balázs M; Gémesi L; Domány G
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5340-4. PubMed ID: 17720494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines.
    Harbert CA; Plattner JJ; Welch WM; Weissman A; Koe BK
    J Med Chem; 1980 Jun; 23(6):635-43. PubMed ID: 6104732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Chloro-2-phenyl-1-benzo[b]thiophene-3-alkanimines, potential antipsychotic agents.
    Kukla MJ; Woo CM; Kehr JR; Miller A
    J Med Chem; 1978 Apr; 21(4):348-52. PubMed ID: 25967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (1-(3-(Phenothiazin-10-yl)propyl)-4-piperidinyl)phenylmethanones, a novel class of long-acting neuroleptic agents.
    Boswell RF; Welstead WJ; Duncan RL; Johnson DN; Funderburk WH
    J Med Chem; 1978 Jan; 21(1):136-9. PubMed ID: 22753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.